The hepatitis B virus (HBV), 1 a member of the hepadnaviruses family, is able to infect only humans or higher primates and has a strong organ tropism for hepatocytes (1). The mechanism of hepatocyte infection induced by this noncytolytic virusis not yet clear. The infectious unit of HBV is an enveloped virion of 42-nm diameter that contains an icosahedral nucleocapsid that encompasses a circular, partly double-stranded DNA molecule with a single strand region of variable length, a DNA-linked protein with functions critical for packaging and DNA replication, including priming, RNA-and DNA-dependent DNA polymerase, and RNAH activities. The HBV envelope that determines the targeting to the host cells and the early entry steps is composed of three proteins anchored in a lipid bilayer, occurring in mature virions in both glycosylated and nonglycosylated forms. The three proteins are called small (S), middle (M), and large (L) surface HBV antigens (HBsAg). They are the translational products of three overlapping open reading frames that start from different initiation codons localized at the 5Ј end of the preS1, preS2, and S regions of the env gene (2). The role of the preS1 region of the L protein appears to be important in cell attachment and consequently in viral infectivity, since preS1 synthetic peptides and corresponding antibodies inhibit virus binding to HepG2 cells (3,4).A cellular receptor is required for HBV binding and penetration in liver cells. Studies in rat hepatoma cells transfected with the HBV genome (5) and transgenic mice with the genome integrated (6) indicate that HBV is able to replicate in rodent cells once it bypasses the attachment and entry steps of infection, so that the absence of specific cellular receptor(s) constitutes the barrier of HBV infection and replication in nonhuman hepatocytes. A number of putative human cellular receptors for HBV have been proposed, including the receptor for immunoglobulin A (IgA), which shows a partial sequence similarity between the Fc region of the IgA ␣ chain and the preS1 domain of the virus (7,8), and the receptor for interleukin-6, due to the presence of a recognition site for the preS1 domain on interleukin-6